Nektar Therapeutics (NKTR) had the highest return between April 4, 2024 and April 12, 2024 by a US stock with a market cap of $1B+, returning 54.6%.
| ASSET | DATE | % RETURN |
|---|---|---|
Nektar Therapeutics (NKTR) | 4/4/2024 - 4/12/2024 | 54.63% |
Janux Therapeutics (JANX) | 4/4/2024 - 4/12/2024 | 42.49% |
OppFi (OPFI) | 4/4/2024 - 4/12/2024 | 27.49% |
TransMedics (TMDX) | 4/4/2024 - 4/12/2024 | 22.18% |
Vera Therapeutics (VERA) | 4/4/2024 - 4/12/2024 | 19.93% |
Perpetua Resources (PPTA) | 4/4/2024 - 4/12/2024 | 19.35% |
Argan (AGX) | 4/4/2024 - 4/12/2024 | 18.45% |
Qilian International (BGM) | 4/4/2024 - 4/12/2024 | 16.74% |
WM Technology (MAPSW) | 4/4/2024 - 4/12/2024 | 15.85% |
Coupang LLC (CPNG) | 4/4/2024 - 4/12/2024 | 14.43% |
Revolution Medicines (RVMD) | 4/4/2024 - 4/12/2024 | 14.15% |
Pan American Silver (PAAS) | 4/4/2024 - 4/12/2024 | 13.71% |
Diversified Energy (DEC) | 4/4/2024 - 4/12/2024 | 13.41% |
STAAR Surgical (STAA) | 4/4/2024 - 4/12/2024 | 13.26% |
Grupo Financiero Galicia SA ADR (GGAL) | 4/4/2024 - 4/12/2024 | 12.97% |
Ducommun (DCO) | 4/4/2024 - 4/12/2024 | 11.99% |
MP Materials (MP) | 4/4/2024 - 4/12/2024 | 11.52% |
Enliven Therapeutics (ELVN) | 4/4/2024 - 4/12/2024 | 11.12% |
Nextdecade (NEXT) | 4/4/2024 - 4/12/2024 | 11.07% |
Adaptive Biotechnologies (ADPT) | 4/4/2024 - 4/12/2024 | 11.07% |
Inspire Medical Systems (INSP) | 4/4/2024 - 4/12/2024 | 10.33% |
Chewy (CHWY) | 4/4/2024 - 4/12/2024 | 10.25% |
WK Kellogg (KLG) | 4/4/2024 - 4/12/2024 | 10.22% |
Figs (FIGS) | 4/4/2024 - 4/12/2024 | 9.29% |
AMTD IDEA (AMTD) | 4/4/2024 - 4/12/2024 | 8.98% |
